跳至主要内容
临床试验/EUCTR2010-020551-31-FI
EUCTR2010-020551-31-FI进行中(未招募)不适用

Randomized study of oral ganciclovir versus i.v. ganciclovir for preemptive therapy of cytomegalovirus infection after stem cell transplantation.

ordic Bone and Marrow Transplantation Group0 个研究点目标入组 168 人开始时间: 2010年5月4日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
168

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Allogeneic SCT recipients > 50 kg of body weight, adults and children > 12 years of age
  • Donor: sibling or an unrelated donor
  • Conditioning: myeloablative and reduced intensity
  • First CMV DNAemia after SCT
  • Patients give their informed consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • B-neutrophils < 1x109/L.
  • Patient unable to take oral medication
  • Acute intestinal GVHD or ongoing grade III-IV liver GVHD
  • Patients with leukaemia in relapse

研究者

发起方
ordic Bone and Marrow Transplantation Group

相似试验